病毒性肺炎治疗的研究进展  

Advances in the treatment of viral pneumonia

作　　者：索涛[1] 范慧[1] 陈国忠[1] SUO Tao;FAN Hui;CHEN Guozhong(Dept.of Respiratory and Critical Care Medicine,Renmin Hospital of Wuhan University,Wuhan 430060,Hubei,China)

机构地区：[1]武汉大学人民医院呼吸与危重症医学科,湖北武汉430060

出　　处：《武汉大学学报（医学版）》2020年第3期378-383,共6页Medical Journal of Wuhan University

摘　　要：随着对肺炎的研究进展,病毒病原体越来越被认为是肺炎的重要病因。超过20种病毒与社区获得性肺炎(CAP)有关。除了美国食品和药物管理局批准的治疗流感肺炎的药物外,对非流感呼吸道病毒的治疗手段有限。为了临床治疗各类病毒性肺炎提供更多的理论依据,本文总结了病毒性肺炎治疗的相关研究进展。As research has progressed, viral pathogens are increasingly recognized as a cause of pneumonia.More than 20 viruses have been linked to community-acquired pneumonia(CAP). Apart from the US Food and Drug Administration approved medications for treatment of influenza pneumonia, the treatment of non-influenza respiratory viruses is limited. In order to provide more theoretical basis for the clinical treatment of viral pneumonia, this paper summarizes the related research progress of viral pneumonia treatment.

关 键 词：病毒性肺炎 治疗 2019新型冠状病毒 

分 类 号：R563.1[医药卫生—呼吸系统]